TG Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) has approved BRIUMVI, for the treatment of relapsing forms of multiple sclerosis (RMS),...
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced that the U.S. Food and Drug Administration (FDA)...
PolarityTE, Inc., a biotechnology company developing regenerative tissue products and biomaterials announced that it signed a non-binding letter of intent (the "LOI") with Michael...
ZielBio, Inc., a clinical-stage biotechnology company discovering new treatments for cancer and other serious diseases through its innovative drug discovery platform, announced that the...
